Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

Circuit-By-Circuit Recap: Justices Send Message To Outliers No Photo Available

Jeff Overley

It was a tough term at the U.S. Supreme Court for two very different circuits — one solidly liberal, one solidly conservative — that h... (more story)

Biggest Decisions Of Mich. Supreme Court So Far This Year No Photo Available

Danielle Ferguson

The Michigan Supreme Court so far this year has handed down a number of decisions marking important changes to criminal law, including... (more story)

What To Watch In Mass. Courts In The Second Half Of 2025 No Photo Available

Chris Villani

Massachusetts courts should be busy through the second half of 2025, with litigation against the Trump administration playing a starri... (more story)